FindTrial
Sign In

Metformin, a weightreducing drug in the obese pediatric population?

Metformin, a weightreducing drug in the obese pediatric population? - Metformin, as a weightreducing drug.

Status
Unknown
Phases
Phase 4
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON30455
Enrollment
40
Registered
2007-10-15
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesitas (obesity) Obesity overweight

Interventions

Metfromin (glucophage 500) and a diet.

Sponsors

Máxima Medisch Centrum
Lead Sponsor

Eligibility

Age
12 Years to 17 Years

Inclusion criteria

Inclusion criteria: Obesity Age 10-18 years

Exclusion criteria

Exclusion criteria: Diabetes mellitus

Design outcomes

Primary

MeasureTime frame
Bodyweight—

Secondary

MeasureTime frame
Effect on the cardiovascular risk profile Effect on the quality of life—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)